CHF64.10
3.39%
SIX Swiss Exchange, Oct 05, 05:30 pm CEST. Closed.
ISIN
CH0011795959
Symbol
DOKA

dormakaba Target price 2026 - Analyst rating & recommendation

dormakaba Classifications & Recommendation

Buy
75%
Hold
25%

dormakaba Price Target

Target Price CHF79.56
Price CHF64.10
Potential
Number of Estimates 11
11 Analysts have issued a price target dormakaba 2027 . The average dormakaba target price is CHF79.56. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 16 analysts: 12 Analysts recommend dormakaba to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the dormakaba stock has an average upside potential 2027 of . Most analysts recommend the dormakaba stock at Purchase.

Sales and Margin forecast 2027, 2028 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Revenue Billion CHF 2.79 3.00
2.71% 7.54%
EBITDA Margin 15.44% 16.19%
3.75% 4.87%
Net Margin 3.47% 4.38%
1.84% 26.09%

12 Analysts have issued a sales forecast dormakaba 2027 . The average dormakaba sales estimate is

CHF3.0b
unlock
. This is
7.54% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF3.2b 15.99%
unlock
, the lowest is
CHF2.8b 0.23%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 CHF2.8b 2.71%
2027
CHF3.0b 7.54%
unlock
2028
CHF3.1b 4.13%
unlock
2029
CHF3.2b 3.90%
unlock
2030
CHF3.4b 4.52%
unlock
2031
CHF3.4b 0.88%
unlock
2032
CHF3.4b 1.96%
unlock
2033
CHF3.5b 1.89%
unlock

11 Analysts have issued an dormakaba EBITDA forecast 2027. The average dormakaba EBITDA estimate is

CHF486m
unlock
. This is
14.77% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CHF529m 24.90%
unlock
, the lowest is
CHF434m 2.37%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 CHF431m 0.94%
2027
CHF486m 12.80%
unlock
2028
CHF527m 8.44%
unlock
2029
CHF570m 8.00%
unlock
2030
CHF655m 14.97%
unlock
2031
CHF685m 4.59%
unlock
2032
CHF716m 4.59%
unlock

EBITDA Margin

2026 15.44% 3.75%
2027
16.19% 4.87%
unlock
2028
16.86% 4.14%
unlock
2029
17.53% 3.97%
unlock

12 dormakaba Analysts have issued a net profit forecast 2027. The average dormakaba net profit estimate is

CHF132m
unlock
. This is
35.58% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF156m 61.18%
unlock
, the lowest is
CHF108m 11.35%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 CHF97.0m 0.92%
2027
CHF132m 35.58%
unlock
2028
CHF147m 12.05%
unlock
2029
CHF144m 2.16%
unlock

Net Margin

2026 3.47% 1.84%
2027
4.38% 26.09%
unlock
2028
4.71% 7.53%
unlock
2029
4.44% 5.73%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Earnings Per Share CHF 2.30 3.16
1.71% 37.39%
P/E 19.61
EV/Sales 0.98

12 Analysts have issued a dormakaba forecast for earnings per share. The average dormakaba EPS is

CHF3.16
unlock
. This is
37.39% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
CHF3.76 63.48%
unlock
, the lowest is
CHF2.60 13.04%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 CHF2.30 1.71%
2027
CHF3.16 37.39%
unlock
2028
CHF3.54 12.03%
unlock
2029
CHF3.47 1.98%
unlock

P/E ratio

Current 26.96 11.86%
2027
19.61 27.25%
unlock
2028
17.50 10.76%
unlock
2029
17.89 2.23%
unlock

Based on analysts' sales estimates for 2027, the dormakaba stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.05 9.48%
2027
0.98 7.13%
unlock
2028
0.94 3.97%
unlock
2029
0.90 3.75%
unlock
2030
0.86 4.34%
unlock
2031
0.87 0.89%
unlock
2032
0.85 1.92%
unlock
2033
0.84 1.86%
unlock

P/S ratio

Current 0.92 11.12%
2027
0.86 7.02%
unlock
2028
0.82 3.96%
unlock
2029
0.79 3.76%
unlock
2030
0.76 4.32%
unlock
2031
0.76 0.89%
unlock
2032
0.75 1.91%
unlock
2033
0.73 1.87%
unlock

Current dormakaba Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
➜
Locked
Locked Sep 21 2026
BAADER EUROPE / ALPHAVALUE
Locked
➜
Locked
Locked Sep 17 2026
RESEARCH PARTNERS AG
Locked
➜
Locked
Locked Sep 09 2026
ODDO BHF
Locked
➜
Locked
Locked Sep 08 2026
BAADER EUROPE / ALPHAVALUE
Locked
➜
Locked
Locked Jul 16 2026
BERENBERG
Locked
➜
Locked
Locked Jul 14 2026
BERENBERG
Locked
➜
Locked
Locked Jul 13 2026
Analyst Rating Date
Locked
BERENBERG:
Locked
➜
Locked
Sep 21 2026
Locked
BAADER EUROPE / ALPHAVALUE:
Locked
➜
Locked
Sep 17 2026
Locked
RESEARCH PARTNERS AG:
Locked
➜
Locked
Sep 09 2026
Locked
ODDO BHF:
Locked
➜
Locked
Sep 08 2026
Locked
BAADER EUROPE / ALPHAVALUE:
Locked
➜
Locked
Jul 16 2026
Locked
BERENBERG:
Locked
➜
Locked
Jul 14 2026
Locked
BERENBERG:
Locked
➜
Locked
Jul 13 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today